中国中医药信息杂志
中國中醫藥信息雜誌
중국중의약신식잡지
CHINESE JOURNAL OF INFORMATION ON TRADITIONAL CHINESE MEDICINE
2013年
9期
6-9,12
,共5页
刘嵋松%孙良梅%王胜圣%董芳%蔡鸿雁%王晓岩%王钰%周建民
劉嵋鬆%孫良梅%王勝聖%董芳%蔡鴻雁%王曉巖%王鈺%週建民
류미송%손량매%왕성골%동방%채홍안%왕효암%왕옥%주건민
中西医结合疗法%初治肺结核病%临床疗效%安全性
中西醫結閤療法%初治肺結覈病%臨床療效%安全性
중서의결합요법%초치폐결핵병%림상료효%안전성
integrated therapy of Chinese medicine and chemical drugs%initial treatment of pulmonary tuberculosis%therapeutic effect%safety
目的评价中西医结合疗法治疗初治继发性肺结核的临床疗效及安全性。方法临床选择1404例符合西医初治继发性肺结核和中医肺痨(肺阴亏虚、气阴两虚、阴虚火旺证候)诊断标准的患者,进行随机、对照、单盲、多中心临床试验。试验组口服西药+中药,对照组单纯口服西药,疗程6个月。观察2组不良反应发生率和临床症状改善情况,评价其临床疗效及安全性。结果试验组可减少治疗中因药物引起的肝损伤及其他不良反应,不良反应发生率组间比较差异有统计学意义(P<0.001)。肺阴虚证治疗2、4、6个月后,阴虚火旺证治疗6个月后,气阴两虚证治疗4、6个月后症状总积分组间比较差异有统计学意义(P<0.001)。中医证候疗效组间比较差异有统计学意义(P<0.001)。安全性评价分层分析组间比较差异有统计学意义(P<0.001)。结论采用中西医结合方法治疗初治继发性肺结核可减少单纯西药治疗引起的不良反应,减轻临床症状,提高临床疗效和安全性。
目的評價中西醫結閤療法治療初治繼髮性肺結覈的臨床療效及安全性。方法臨床選擇1404例符閤西醫初治繼髮性肺結覈和中醫肺癆(肺陰虧虛、氣陰兩虛、陰虛火旺證候)診斷標準的患者,進行隨機、對照、單盲、多中心臨床試驗。試驗組口服西藥+中藥,對照組單純口服西藥,療程6箇月。觀察2組不良反應髮生率和臨床癥狀改善情況,評價其臨床療效及安全性。結果試驗組可減少治療中因藥物引起的肝損傷及其他不良反應,不良反應髮生率組間比較差異有統計學意義(P<0.001)。肺陰虛證治療2、4、6箇月後,陰虛火旺證治療6箇月後,氣陰兩虛證治療4、6箇月後癥狀總積分組間比較差異有統計學意義(P<0.001)。中醫證候療效組間比較差異有統計學意義(P<0.001)。安全性評價分層分析組間比較差異有統計學意義(P<0.001)。結論採用中西醫結閤方法治療初治繼髮性肺結覈可減少單純西藥治療引起的不良反應,減輕臨床癥狀,提高臨床療效和安全性。
목적평개중서의결합요법치료초치계발성폐결핵적림상료효급안전성。방법림상선택1404례부합서의초치계발성폐결핵화중의폐로(폐음우허、기음량허、음허화왕증후)진단표준적환자,진행수궤、대조、단맹、다중심림상시험。시험조구복서약+중약,대조조단순구복서약,료정6개월。관찰2조불량반응발생솔화림상증상개선정황,평개기림상료효급안전성。결과시험조가감소치료중인약물인기적간손상급기타불량반응,불량반응발생솔조간비교차이유통계학의의(P<0.001)。폐음허증치료2、4、6개월후,음허화왕증치료6개월후,기음량허증치료4、6개월후증상총적분조간비교차이유통계학의의(P<0.001)。중의증후료효조간비교차이유통계학의의(P<0.001)。안전성평개분층분석조간비교차이유통계학의의(P<0.001)。결론채용중서의결합방법치료초치계발성폐결핵가감소단순서약치료인기적불량반응,감경림상증상,제고림상료효화안전성。
Objective To observe the effect of integrated therapy of Chinese medicine and chemical drugs on adverse reaction and curative effect of initial treatment of secondary pulmonary tuberculosis. Methods Totally 1404 patients with secondary pulmonary tuberculosis and TCM lung consumption diagnostic criteria (syndrome of lung yin deficiency, qi-yin deficiency, yin-deficiency caused excessive fire) were chosen for single blind, randomized, controlled, multicenter clinical trials. Trial group was given 2HRZE/4HR, 1 time/day with Chinese medicine 2 or 3 times/day, and control group was given 2HRZE/4HR only for six months. The adverse reactions and clinical symptoms were observed to evaluate clinical efficacy and safety. Results In terms of reducing liver damage and other adverse reactions, the ratio of trial group had statistical difference with that of control group (P<0.001). In symptom scores of lung yin deficiency syndrome treated for 2, 4, 6 months, yin-deficiency caused excessive fire syndrome treated for 6 months, qi-yin deficiency syndrome treated for 4, 6 months, the differences between the two groups were significant (P<0.001). TCM syndrome curative effect between the two groups was statistical different (P<0.001). Safety evaluation result between the two groups was statistical different by tratified analysis (P<0.001). Conclusion Integrated therapy of Chinese medicine and chemical drugs can improve the symptoms and reduce adverse reactions caused by chemical drugs. It can enhance the curative effect and safety.